Skip to content

Using high frame-rate contrast-enhanced ultrasonography to diagnose metastasis of papillary thyroid carcinoma in indeterminate cervical lymph nodes: A randomized controlled trial

Using high frame-rate contrast-enhanced ultrasonography to diagnose metastasis of papillary thyroid carcinoma in indeterminate cervical lymph nodes: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083762
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

600# Tian He Road, Guangzhou, P.R. China

Interventions

Gold Standard:ultrasound-guided fine needle aspiration of lymph node
Index test:high frame-rate contrast-enhanced ultrasonography

Sponsors

the Third Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) PTC Patients 2) indeterminate cervical lymph nodes determined by high frequency ultrasonography, and meets all the following: a. absence of a hilum; b. one of the following characteristics appears: round shape, increased short axis (=8mm in level II and =5mm levels III and IV), increased central vascularization; c. without microcalcifications, partially cystic appearance, peripheral or diffusely increased vascularization, or hyperechoic tissue looking like thyroid; 3) without history of chemotherapy or radiation therapy for cervical lymph node 4) = 18 years old 5) able to comply with the requirements of the experiment and cooperate with subsequent puncture biopsy (within 3 months after contrast-enhanced ultrasonography) 6) signing informed consent form

Exclusion criteria

Exclusion criteria: 1) allergic of ultrasound contrast agent 2) severe cardiopulmonary dysfunction 3) Pregnant or lactating period 4) with a history of mental illness, personality disorders, cognitive impairment or brain organic diseases, unable to cooperate with contrast-enhanced ultrasonography or pathological examination

Design outcomes

Primary

MeasureTime frame
specificity;

Secondary

MeasureTime frame
sensitivity;accuracy;positive predictive value;negative predictive value;area under the curve;

Countries

P.R. China

Contacts

Public ContactBo-wen Zheng

the Third Affiliated Hospital of Sun Yat-sen University

bovenzu@126.com+86 138 2606 6490

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026